How Has The Flow Cytometry in Oncology and Immunology Market Progressed and What is the Future Growth Forecast?
The flow cytometry in oncology and immunology market size has seen considerable growth in the recent years, expanding from $2.11 billion in 2024 to a projected $2.33 billion in 2025 at a compound annual growth rate (CAGR) of 10.4%. This rapid growth can be attributed to advancements in cancer research, a rise in autoimmune diseases, and increased participation in drug development and clinical trials. The future forecasts predict further expansion with the market size reaching $3.46 billion in 2029, at the same CAGR of 10.4%. The imminent growth is anticipated to stem from integration with genomics and proteomics, expanding applications in infectious diseases, and increased adoption of single-cell analysis.
Get Your Free Sample of The Global Flow Cytometry In Oncology And Immunology Global Market Report 2024 Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=12469&type=smp
What Are The Drivers Steering The Growth Of The Flow Cytometry in Oncology and Immunology Market?
One significant factor driving the growth of the flow cytometry in the oncology and immunology market is the rising prevalence of cancer. This group of disorders is characterized by uncontrolled growth and spread of abnormal cells in the body, and it’s widely studied using flow cytometry techniques. For instance, in Macmillan Cancer Support, a UK-based healthcare charity, revealed that 3 million people had cancer in 2020, and projections suggest this number could rise to 5.3 million by 2040. Consequently, this rising prevalence of cancer is fueling the demand for flow cytometry in oncology and immunology research.
What Are The Primary Segments In The Flow Cytometry in Oncology and Immunology Market?
The flow cytometry in oncology and immunology market is divided into several segments:
– By Type: Immunology, Oncology
– By Technology: Cell-Based Flow Cytometry, Bead-Based Flow Cytometry
– By Application: Translational Research, Clinical Research
– By End User: Hospitals, Diagnostic Laboratories, Reference Laboratories, Pharmaceutical And Biotechnology Companies, Academic Research Institutes, Contract Research Organizations, Other End Users
Order your report now for swift delivery: https://www.thebusinessresearchcompany.com/report/flow-cytometry-in-oncology-and-immunology-global-market-report
Who Are The Leaders in The Flow Cytometry in Oncology and Immunology Market?
Prominent companies operating in the flow cytometry in oncology and immunology market include Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, DiaSorin S.p.A, BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason.
What Trends Are Stimulating The Growth Of The Flow Cytometry in Oncology and Immunology Market? Technological advancements are a key trend stimulating growth in the flow cytometry in oncology and immunology market. Companies operating in these markets are adopting new technologies to maintain their market position. For example, Becton Dickinson, and Company, a U.S-based medical technology provider, launched BD Research Cloud to simplify and enhance the flow cytometry process for researchers and enable them to achieve quicker insights.
Which Region Emerged As The Leader In The Flow Cytometry in Oncology and Immunology Market?
In 2024, North America emerged as the leading region in the flow cytometry in oncology and immunology market. The report also covers regions such as Asia-Pacific, Western Europe, Eastern Europe, South America, Middle East, and Africa.
What Does The Flow Cytometry In Oncology And Immunology Global Market Report 2024 Report 2025 Offer?
Flow cytometry is a powerful analytical technique used in oncology and immunology to measure and analyze the physical and chemical characteristics of cells or particles. The Flow Cytometry In Oncology And Immunology Global Market Report 2024 research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights: https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12469
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
